Cencora, Inc. - Investor Relations

Corporate overview

Cencora, formerly AmerisourceBergen, is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers, and pharmacies to improve product access and efficiency throughout the healthcare supply chain.

Latest quarterly results

See all quarters

Financial highlights

FY25 Revenue

U.S. Healthcare Solutions: $284,964M
International Healthcare Solutions: $28,329M
Other: $8,158M

1. Includes $118M of intersegment eliminations.
2. Beginning in the first quarter of fiscal 2026, in addition to the reportable segments for U.S. Healthcare Solutions and International Healthcare Solutions, the Company will begin reporting certain businesses that it is exploring strategic alternatives for under "Other." For further detail on fiscal 2025 revised reportable segment information, please reference Exhibit 99.2 to the Company's form 8-K dated November 5, 2025.

FY25 Adjusted operating income

U.S. Healthcare Solutions: $3,283M
International Healthcare Solutions: $588M
Other: $352M

3. Note: Note: FY25 GAAP Operating Income of $2,629M. For more information and a reconciliation of non-GAAP financial measures, refer to the Company's Current Report on Form 8-K furnished under item 2.02 on November 5, 2025

Cencora: By the numbers

$300B+

Annual revenue

51,000+

Team Members

150+

Global offices

Summary Annual Report

Recent news

See all news

Events and presentations

See all events

Notice Of Pendency And Proposed Settlement Of Stockholder Derivative Action, Settlement Hearing, And Right To Appear

Stipulation of Settlement

Cencora stockholder derivative litigation